• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-10通过使炎性类成纤维细胞重极化来挽救慢性淋巴细胞白血病患者的生存期。

IL-10 Rescues CLL Survival through Repolarization of Inflammatory Nurse-like Cells.

作者信息

Domagala Marcin, Ysebaert Loïc, Ligat Laetitia, Lopez Frederic, Fournié Jean-Jacques, Laurent Camille, Poupot Mary

机构信息

Centre de Recherches en Cancérologie de Toulouse, Inserm UMR1037, 31037 Toulouse, France.

Université Toulouse III Paul-Sabatier, 31400 Toulouse, France.

出版信息

Cancers (Basel). 2021 Dec 21;14(1):16. doi: 10.3390/cancers14010016.

DOI:10.3390/cancers14010016
PMID:35008174
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8750769/
Abstract

Tumor-associated macrophages (TAMs) in chronic lymphocytic leukemia (CLL) are also called nurse-like cells (NLC), and confer survival signals through the release of soluble factors and cellular contacts. While in most patient samples the presence of NLC in co-cultures guarantees high viability of leukemic cells in vitro, in some cases this protective effect is absent. These macrophages are characterized by an "M1-like phenotype". We show here that their reprogramming towards an M2-like phenotype (tumor-supportive) with IL-10 leads to an increase in leukemic cell survival. Inflammatory cytokines, such as TNF, are also able to depolarize M2-type protective NLC (decreasing CLL cell viability), an effect which is countered by IL-10 or blocking antibodies. Interestingly, both IL-10 and TNF are implied in the pathophysiology of CLL and their elevated level is associated with bad prognosis. We propose that the molecular balance between these two cytokines in CLL niches plays an important role in the maintenance of the protective phenotype of NLCs, and therefore in the survival of CLL cells.

摘要

慢性淋巴细胞白血病(CLL)中的肿瘤相关巨噬细胞(TAM)也被称为类护士细胞(NLC),它们通过释放可溶性因子和细胞接触来传递生存信号。虽然在大多数患者样本中,共培养体系中NLC的存在可确保白血病细胞在体外具有较高的活力,但在某些情况下,这种保护作用并不存在。这些巨噬细胞具有“M1样表型”。我们在此表明,用白细胞介素-10(IL-10)将它们重编程为M2样表型(肿瘤支持性)会导致白血病细胞存活率增加。炎性细胞因子,如肿瘤坏死因子(TNF),也能够使M2型保护性NLC去极化(降低CLL细胞活力),而IL-10或阻断抗体可对抗这种作用。有趣的是,IL-10和TNF都与CLL的病理生理学有关,它们水平的升高与不良预后相关。我们提出,CLL微环境中这两种细胞因子之间的分子平衡在维持NLC的保护表型中起重要作用,因此对CLL细胞的存活也很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b1b/8750769/3908fe4a8132/cancers-14-00016-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b1b/8750769/dc6e957cc147/cancers-14-00016-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b1b/8750769/c334084ee5e9/cancers-14-00016-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b1b/8750769/26b625e42881/cancers-14-00016-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b1b/8750769/3908fe4a8132/cancers-14-00016-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b1b/8750769/dc6e957cc147/cancers-14-00016-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b1b/8750769/c334084ee5e9/cancers-14-00016-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b1b/8750769/26b625e42881/cancers-14-00016-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b1b/8750769/3908fe4a8132/cancers-14-00016-g004.jpg

相似文献

1
IL-10 Rescues CLL Survival through Repolarization of Inflammatory Nurse-like Cells.白细胞介素-10通过使炎性类成纤维细胞重极化来挽救慢性淋巴细胞白血病患者的生存期。
Cancers (Basel). 2021 Dec 21;14(1):16. doi: 10.3390/cancers14010016.
2
Macrophage Polarization in Chronic Lymphocytic Leukemia: Nurse-Like Cells Are the Caretakers of Leukemic Cells.慢性淋巴细胞白血病中的巨噬细胞极化:类护士细胞是白血病细胞的守护者。
Biomedicines. 2020 Nov 19;8(11):516. doi: 10.3390/biomedicines8110516.
3
Development of a cell-line model to mimic the pro-survival effect of nurse-like cells in chronic lymphocytic leukemia.建立细胞系模型模拟慢性淋巴细胞白血病中类滋养细胞的促生存作用。
Leuk Lymphoma. 2021 Jan;62(1):45-57. doi: 10.1080/10428194.2020.1811274. Epub 2020 Aug 28.
4
Circulating microenvironment of CLL: are nurse-like cells related to tumor-associated macrophages?CLL 的循环微环境:类滋养细胞与肿瘤相关巨噬细胞有关吗?
Blood Cells Mol Dis. 2013 Apr;50(4):263-70. doi: 10.1016/j.bcmd.2012.12.003. Epub 2013 Jan 11.
5
BDNF belongs to the nurse-like cell secretome and supports survival of B chronic lymphocytic leukemia cells.BDNF 属于支持 B 慢性淋巴细胞白血病细胞存活的类神经胶质细胞分泌组。
Sci Rep. 2020 Jul 28;10(1):12572. doi: 10.1038/s41598-020-69307-1.
6
Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia.集落刺激因子-1受体是慢性淋巴细胞白血病中类滋养细胞存活所必需的。
Clin Cancer Res. 2016 Dec 15;22(24):6118-6128. doi: 10.1158/1078-0432.CCR-15-3099. Epub 2016 Jun 22.
7
Nurse-like cells promote CLL survival through LFA-3/CD2 interactions.类护士细胞通过淋巴细胞功能相关抗原-3/CD2相互作用促进慢性淋巴细胞白血病的存活。
Oncotarget. 2016 Nov 26;8(32):52225-52236. doi: 10.18632/oncotarget.13660. eCollection 2017 Aug 8.
8
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia.依鲁替尼可改变慢性淋巴细胞白血病中单核细胞/巨噬细胞群体的功能。
Oncotarget. 2016 Oct 4;7(40):65968-65981. doi: 10.18632/oncotarget.11782.
9
Reprogramming Nurse-like Cells with Interferon γ to Interrupt Chronic Lymphocytic Leukemia Cell Survival.用γ干扰素重编程类护士细胞以中断慢性淋巴细胞白血病细胞的存活
J Biol Chem. 2016 Jul 1;291(27):14356-14362. doi: 10.1074/jbc.M116.723551. Epub 2016 May 13.
10
Genomic and phenotypic characterization of nurse-like cells that promote drug resistance in chronic lymphocytic leukemia.促进慢性淋巴细胞白血病耐药的类淋巴母细胞的基因组和表型特征。
Leuk Lymphoma. 2011 Jul;52(7):1404-6. doi: 10.3109/10428194.2011.568078.

引用本文的文献

1
Extracellular vesicles from chronic lymphocytic leukemia cells promote leukemia aggressiveness by inducing the differentiation of monocytes into nurse-like cells via an RNA-dependent mechanism.慢性淋巴细胞白血病细胞来源的细胞外囊泡通过RNA依赖机制诱导单核细胞分化为类滋养细胞,从而促进白血病的侵袭性。
Hemasphere. 2025 Jan 16;9(1):e70068. doi: 10.1002/hem3.70068. eCollection 2025 Jan.
2
Rewiring the T cell-suppressive cytokine landscape of the tumor microenvironment: a new frontier for precision anti-cancer therapy.重塑肿瘤微环境中T细胞抑制性细胞因子格局:精准抗癌治疗的新前沿
Front Immunol. 2024 Aug 30;15:1418527. doi: 10.3389/fimmu.2024.1418527. eCollection 2024.
3

本文引用的文献

1
Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia.白细胞介素-10 抑制增强了慢性淋巴细胞白血病中 T 细胞抗肿瘤免疫和对检查点阻断的反应。
Leukemia. 2021 Nov;35(11):3188-3200. doi: 10.1038/s41375-021-01217-1. Epub 2021 Mar 17.
2
Loss of interleukin-10 activates innate immunity to eradicate adult T-cell leukemia-initiating cells.白细胞介素-10 的缺失激活固有免疫以清除成人 T 细胞白血病起始细胞。
Haematologica. 2021 May 1;106(5):1443-1456. doi: 10.3324/haematol.2020.264523.
3
Macrophage Polarization in Chronic Lymphocytic Leukemia: Nurse-Like Cells Are the Caretakers of Leukemic Cells.
Analysis of Mutational Status of , and Cytokine Polymorphisms as Prognostic Factors in Chronic Lymphocytic Leukemia: The Romanian Experience.
慢性淋巴细胞白血病中 基因突变状态分析及细胞因子多态性作为预后因素:罗马尼亚经验。
Int J Mol Sci. 2024 Feb 1;25(3):1799. doi: 10.3390/ijms25031799.
4
Active Hexose-Correlated Compound Shows Direct and Indirect Effects against Chronic Lymphocytic Leukemia.活性己糖相关化合物对慢性淋巴细胞白血病具有直接和间接作用。
Nutrients. 2023 Dec 18;15(24):5138. doi: 10.3390/nu15245138.
5
Macrophage-Based Therapeutic Strategies in Hematologic Malignancies.血液系统恶性肿瘤中基于巨噬细胞的治疗策略
Cancers (Basel). 2023 Jul 22;15(14):3722. doi: 10.3390/cancers15143722.
6
Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers.慢性淋巴细胞白血病的治疗抵抗:新老分子生物标志物。
Int J Mol Sci. 2023 Jun 20;24(12):10374. doi: 10.3390/ijms241210374.
7
An agent-based model of monocyte differentiation into tumour-associated macrophages in chronic lymphocytic leukemia.慢性淋巴细胞白血病中单核细胞分化为肿瘤相关巨噬细胞的基于主体的模型。
iScience. 2023 May 19;26(6):106897. doi: 10.1016/j.isci.2023.106897. eCollection 2023 Jun 16.
8
Analysis of causes for poor persistence of CAR-T cell therapy .CAR-T 细胞疗法持久性差的原因分析。
Front Immunol. 2023 Jan 25;14:1063454. doi: 10.3389/fimmu.2023.1063454. eCollection 2023.
9
Major pathways involved in macrophage polarization in cancer.癌症中巨噬细胞极化涉及的主要途径。
Front Immunol. 2022 Oct 17;13:1026954. doi: 10.3389/fimmu.2022.1026954. eCollection 2022.
10
Nurselike cells sequester B cells in disorganized lymph nodes in chronic lymphocytic leukemia via alternative production of CCL21.成纤维样细胞通过 CCL21 的替代产生将 B 细胞隔离在慢性淋巴细胞白血病中紊乱的淋巴结内。
Blood Adv. 2022 Aug 23;6(16):4691-4704. doi: 10.1182/bloodadvances.2021006169.
慢性淋巴细胞白血病中的巨噬细胞极化:类护士细胞是白血病细胞的守护者。
Biomedicines. 2020 Nov 19;8(11):516. doi: 10.3390/biomedicines8110516.
4
BDNF belongs to the nurse-like cell secretome and supports survival of B chronic lymphocytic leukemia cells.BDNF 属于支持 B 慢性淋巴细胞白血病细胞存活的类神经胶质细胞分泌组。
Sci Rep. 2020 Jul 28;10(1):12572. doi: 10.1038/s41598-020-69307-1.
5
Bone marrow hematopoietic dysfunction in untreated chronic lymphocytic leukemia patients.未治疗的慢性淋巴细胞白血病患者的骨髓造血功能障碍。
Leukemia. 2019 Mar;33(3):638-652. doi: 10.1038/s41375-018-0280-0. Epub 2018 Oct 5.
6
Association of blood IgG with tumor necrosis factor-alpha and clinical course of chronic lymphocytic leukemia.血 IgG 与肿瘤坏死因子-α的关系及其与慢性淋巴细胞白血病临床过程的关系。
EBioMedicine. 2018 Sep;35:222-232. doi: 10.1016/j.ebiom.2018.08.045. Epub 2018 Aug 30.
7
Anti-IL-10-mediated Enhancement of Antitumor Efficacy of a Dendritic Cell-targeting MIP3α-gp100 Vaccine in the B16F10 Mouse Melanoma Model Is Dependent on Type I Interferons.抗白细胞介素-10 增强树突状细胞靶向 MIP3α-gp100 疫苗在 B16F10 小鼠黑色素瘤模型中的抗肿瘤疗效依赖于 I 型干扰素。
J Immunother. 2018 May;41(4):181-189. doi: 10.1097/CJI.0000000000000212.
8
Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin.肿瘤坏死因子受体信号转导是慢性淋巴细胞白血病的驱动因素,类黄酮染料木黄酮可通过其靶向进行治疗。
Haematologica. 2018 Apr;103(4):688-697. doi: 10.3324/haematol.2017.177808. Epub 2018 Jan 11.
9
Nurse-like cells promote CLL survival through LFA-3/CD2 interactions.类护士细胞通过淋巴细胞功能相关抗原-3/CD2相互作用促进慢性淋巴细胞白血病的存活。
Oncotarget. 2016 Nov 26;8(32):52225-52236. doi: 10.18632/oncotarget.13660. eCollection 2017 Aug 8.
10
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia.依鲁替尼可改变慢性淋巴细胞白血病中单核细胞/巨噬细胞群体的功能。
Oncotarget. 2016 Oct 4;7(40):65968-65981. doi: 10.18632/oncotarget.11782.